Broadwater Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.37M Sell
21,130
-913
-4% -$213K 3.89% 6
2026
Q1
$4.56M Hold
22,043
3.41% 7
2025
Q4
$4.56M Hold
22,043
3.41% 7
2025
Q3
$4.09M Sell
22,043
-3,354,190
-99% -$575M 2.99% 7
2025
Q2
$3.38B Buy
3,376,233
+3,354,130
+15,175% +$516M 2.63% 9
2025
Q1
$3.67M Hold
22,103
2.87% 8
2024
Q4
$3.2M Sell
22,103
-1,365
-6% -$212K 2.45% 9
2024
Q3
$3.8M Hold
23,468
2.8% 8
2024
Q2
$3.43M Sell
23,468
-3,850
-14% -$573K 2.64% 10
2024
Q1
$4.32M Sell
27,318
-660
-2% -$105K 3.32% 6
2023
Q4
$4.39M Buy
+27,978
New +$4.29M 3.44% 4

Other funds holding JNJ

Broadwater Capital's JNJ Position: Q2 2026 in Review

Broadwater Capital reduced its Johnson & Johnson (JNJ) stake by 4.1% in Q2 2026, selling an estimated $213K and leaving 21,130 shares worth $5.37M. The position accounts for 3.89% of the portfolio, ranked #6.

Broadwater Capital first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.38B in Q2 2025. 2,030 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Broadwater Capital held 21,130 shares of Johnson & Johnson worth $5.37M as of Q2 2026.
  • Broadwater Capital sold 913 Johnson & Johnson shares in Q2 2026, an estimated $213K.
  • Johnson & Johnson made up 3.89% of Broadwater Capital's portfolio in Q2 2026, its #6 holding.
  • Broadwater Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Broadwater Capital's Johnson & Johnson position peaked at $3.38B in Q2 2025.
  • 2,030 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Broadwater Capital's 13F filing for Q2 2026, filed 24 Jul 2026.